Synercid (quinupristin-dalfopristin) is now available for emergency use

February 1996

Rhone-Poulenc Rorer's investigational antibiotic Synercid (quinupristin-dalfopristin) is now available for emergency use...for certain resistant gram positive infections.

It's being used for vancomycin-resistant enterococci (VRE)...and methicillin-resistant Staph aureus (MRSA) or Staph epidermidis in patients who can't take vancomycin. It also seems to be active against penicillin-resistant pneumococcus.

Both quinupristin and dalfopristin are in a new class of antibiotics called streptogramins. The combination has synergistic effects. (Hence the name Synercid.)

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote